09.08.2022 16:00

Fictiv Delivers U.S. Injection Molding Solutions to Address Industry's Biggest Supply Chain Issues

Folgen
Werbung

SAN FRANCISCO, Aug. 9, 2022 /PRNewswire/ -- Fictiv, the operating system for custom manufacturing, announced today that in response to customer demand, it is expanding its injection molding manufacturing partner network in the U.S. This will increase capacity for domestic resources, offering customers more flexibility and reduced supply chain risks.

Fictiv customer TransMed7 cut new product development time on five new medical devices from 10 years to two by using Fictiv’s cloud-based digital manufacturing platform.

"At Fictiv, our goal is to offer the highest quality parts that meet our customers' changing needs," said Jean Olivieri, chief operations officer at Fictiv. "We serve a variety of industries, and each customer may have different priorities such as lead times, price, or risk. We listen to them and offer optimized solutions."

According to Fictiv's 2022 State of Manufacturing Report, 65% of U.S. manufacturing companies would prefer to increase onshoring due to continued international supply chain disruptions. With more customers seeking options to manufacture domestically, Fictiv's geographically diversified injection molding services provides customers with the flexibility to choose the best solutions for their business.

"Injection molding plays a critical role in scaling the product offerings for several business units of our organization," said Dr. James Vetter, co-founder and chief medical officer of TransMed7. "With today's continuing concerns about unexpected supply chain issues, it is immensely comforting to have Fictiv as a partner, not just for overseas production but also for domestic manufacturing resources. Fictiv's proven track record of dependable communication at key points in component development, final scaling processes, and meticulous attention to detail have always been huge strengths and we are pleased to learn they are expanding operations in the U.S."

Fictiv offers injection molding services for medical, aerospace, robotics, automotive, and consumer electronics applications. To learn more about Fictiv's injection molding services, visit the company's website.

About Fictiv

Fictiv is the operating system (OS) for custom manufacturing that makes it faster, easier, and more efficient to source and supply mechanical parts. Its intelligent OS, supported by best-in-class operations talent, orchestrates a network of highly vetted and managed partners around the globe for fast, high-quality manufacturing, from quote to delivery. To date, Fictiv has manufactured more than 20 million parts for early-stage companies and large enterprises alike, helping them innovate with agility and get products to market faster.

 

Fictiv logo (PRNewsfoto/Fictiv)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/fictiv-delivers-us-injection-molding-solutions-to-address-industrys-biggest-supply-chain-issues-301602378.html

SOURCE Fictiv

Werbung
Werbung
Werbung
Neue Funktionen als Erstes nutzen
Sie nutzen finanzen.net regelmäßig? Dann nutzen Sie jetzt neue Funktionen als Erstes!
Hier informieren!
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

DAX dreht ins Plus -- US-Börsen mit Gewinnen -- Tesla-Auslieferungen enttäuschen -- Vodafone will Three UK übernehmen -- RWE plant Milliardenkauf- Accelleron-IPO, Porsche, Sixt. METRO im Fokus

Zunehmende Beschwerden über Deutsche Post. United Internet hebt Gewinnprognose an. Prosus bläst Übernahme von indischer Billdesk ab. Sixt erwartet "im Großen und Ganzen stabile Entwicklung". Intel stößt Börsengang der Autotochter an. JPMorgan senkt Rating für Lieferando-Mutter Just Eat Takeaway.com.

Umfrage

Glauben Sie, dass es in den kommenden sechs Monaten schwieriger wird, die eigenen Renditeerwartungen zu erzielen?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln